Inloggad som:

Transform

Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.

Transform
A global randomises multicentre phase 3 trial to compare the efficacy and safety of JCAR017 to standard of care in adult subjects with high-risk, transplanteligible relapsed or refractory aggressive B-cell non-hodgkin lymphomas (TRANSFORM)
A global randomises multicentre phase 3 trial to compare the efficacy and safety of JCAR017 to standard of care in adult subjects with high-risk, transplanteligible relapsed or refractory aggressive B-cell non-hodgkin lymphomas (TRANSFORM)
PLACEHOLDER
Mer information om studien för vårdgivare
Behandling
Fas 3
Palliativ
Företag

Studien ändrades senast av: epiadmin (2020-01-29)

Tillbaka till listan